EUVIMEDEUVIMED entdecken
Crossref

Up‐regulation of the kinase LRRK2, in enteric glia contributes to mucosal barrier impairment in Parkinson's disease via secretory autophagy

Vanessa D'Antongiovanni iD, Clarissa Pierucci iD, Cristina Segnani iD, Chiara Ippolito iD, Clelia Di Salvo iD, Elena Lucarini iD, Luca Antonioli iD, Matteo Fornai iD, Nunzia Bernardini iD, Pascal Derkinderen iD, Carmelo Scarpignato iD, Carolina Pellegrini iD

British Journal of Pharmacology · 2026

DOI: 10.1111/bph.70623 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2026. Verfasst von Vanessa D'Antongiovanni und 11 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Human Histology and Embryology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Parkinson Disease, Neuroglia, Intestinal Mucosa. Die Arbeit nennt 80 Literaturangaben. Gefördert von: MUR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Patients with Parkinson's disease (PD) show intestinal epithelial barrier (IEB) alterations, enteric gliosis and inflammation that could contribute to gastrointestinal symptoms. Moreover, changes in leucine rich‐repeat kinase 2 (LRRK2) expression/activity have been associated with PD development and related intestinal inflammation. However, the molecular determinants linking LRRK2, enteric gliosis and IEB impairment remain unclear. Therefore, we investigated the role of LRRK2 in IEB changes associated with PD, focusing on its role in the interplay between enteric glial cells (EGCs) and intestinal epithelial cells (IECs). Experimental Approach Human A53T α‐synuclein transgenic (Tg) mice (9 months old) were provided a model of early PD. Central neuroinflammation was studied by IBA‐1 staining. Intestinal motility, colonic α‐synuclein and LRRK2 expression were assessed. Enteric gliosis was evaluated by detection of GFAP + cells co‐expressing LRRK2; IEB was tested by mucins detection and quantification of Muc‐2, tight junction proteins and secretory autophagy. In vitro co‐cultures between EGCs and IECs were performed to investigate glial LRRK2‐mediated gut barrier alterations. Key Results A53T mice, without central neuroinflammation, showed intestinal disturbances, colonic α‐synuclein accumulation and an increase in colonic GFAP + /LRRK2 + glial cells before brain pathology. Moreover, PD animals displayed IEB alterations and increased colonic autophagosomes, suggesting a shift towards secretory autophagy. In co‐culture experiments, α‐synuclein and lipopolysaccharide promoted enteric gliosis and LRRK2 up‐regulation in glial cells, contributing to IEB impairment via secretory autophagy. Conclusions and Implications These changes could influence bowel symptoms and central pathology associated with PD, via the gut‐brain axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2Parkinson DiseaseNeurogliaIntestinal MucosaAutophagyAnimalsUp-RegulationHumansMice, TransgenicMicealpha-SynucleinIntestinal Barrier FunctionMaleMice, Inbred C57BLDisease Models, Animal

Stichwörter der Autor:innen

LRRK2autophagyenteric glial cellsintestinal epithelial barrierneurodegenerative disorders

Substanzen

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2alpha-SynucleinLrrk2 protein, mouseLRRK2 protein, human

Autor:innen und Institutionen

  • Unit of Human Histology and Embryology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Department of Neuroscience, Psychology, Drug Research and Child Health, Neurofarba, Pharmacology and Toxicology Section, University of Florence, Florence, Italy.
  • Nantes Université, CHU Nantes, Nantes, France.
  • Department of Health Sciences, United Campus of Malta, Msida, Malta.

ORCID-Profile: Vanessa D'Antongiovanni, Clarissa Pierucci, Cristina Segnani, Chiara Ippolito, Clelia Di Salvo, Elena Lucarini, Luca Antonioli, Matteo Fornai, Nunzia Bernardini, Pascal Derkinderen, Carmelo Scarpignato, Carolina Pellegrini

Förderung

  • MUR

Zitieren

APA

D'Antongiovanni, V., Pierucci, C., Segnani, C., Ippolito, C., Di Salvo, C., Lucarini, E., Antonioli, L., Fornai, M., Bernardini, N., Derkinderen, P., Scarpignato, C., & Pellegrini, C. (2026). Up‐regulation of the kinase LRRK2, in enteric glia contributes to mucosal barrier impairment in Parkinson's disease via secretory autophagy. British Journal of Pharmacology. https://doi.org/10.1111/bph.70623

Vancouver

D'Antongiovanni V, Pierucci C, Segnani C, Ippolito C, Di Salvo C, Lucarini E, et al. Up‐regulation of the kinase LRRK2, in enteric glia contributes to mucosal barrier impairment in Parkinson's disease via secretory autophagy. British Journal of Pharmacology. 2026. doi:10.1111/bph.70623

BibTeX
@article{DAntongiovanni2026,
  author = {D'Antongiovanni, Vanessa and Pierucci, Clarissa and Segnani, Cristina and Ippolito, Chiara and Di Salvo, Clelia and Lucarini, Elena and Antonioli, Luca and Fornai, Matteo and Bernardini, Nunzia and Derkinderen, Pascal and Scarpignato, Carmelo and Pellegrini, Carolina},
  title = {Up‐regulation of the kinase LRRK2, in enteric glia contributes to mucosal barrier impairment in Parkinson's disease via secretory autophagy},
  journal = {British Journal of Pharmacology},
  year = {2026},
  doi = {10.1111/bph.70623}
}
Kostenlos starten →